← Open Payments lookup

ADDI GEORGANTZIS: Open Payments

NPI 1083280317 · ENGLEWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,594 in 19 payments from 8 companies in 2025. Trend: 2023 $79 · 2024 $175 · 2025 $1,594

Consulting: $980Food & beverage: $614
CompanyPaymentsAmount
Genmab U.S., Inc.2$1,003
Janssen Biotech, Inc.6$359
Immunocore Limited2$67
Genentech USA, Inc.3$58
ABBVIE INC.3$52
TAIHO ONCOLOGY, INC.1$19
Astellas Pharma US Inc1$19
Celgene Corporation1$17

Products named: EPKINLY, RYBREVANT, TECVAYLI, KIMMTRAK, IMBRUVICA, Itovebi, LONSURF, Xospata.

Industry payments across NJ — which companies pay providers there.